NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Long Term Debt

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) currently reports a long-term debt of $56K as of June 2026. That compares with $210K in the prior-year period — down 72.8% year over year. Use the charts on this page to explore NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s long-term debt history and peer comparisons.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s long-term debt decreased from $210K to $56K — a 72.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) reported $56K in long-term debt as of June 2026. That compares with $210K in the prior-year period — down 72.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $56K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NewAmsterdam Pharma Company NV - Warrants (15/11/2027), and consider following NAMSW for alerts when major investors trade the stock.